Return to search

AmpiMed Raising $22 Million

AmpiMed Corp., a Tucson, Ariz.-based oncology drug startup, has secured $5 million of a $22 million Series C round, according to a regulatory filing. Backers include BioMed Venture Partners, Biotech Insight Ventures, Solstice Capital and Valley Ventures. www.amplimed.com